Taking stock of current societal, political and academic stakeholders in the Canadian healthcare knowledge translation agenda by Newton, Mandi S & Scott-Findlay, Shannon
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Implementation Science
Open Access Debate
Taking stock of current societal, political and academic 
stakeholders in the Canadian healthcare knowledge translation 
agenda
Mandi S Newton* and Shannon Scott-Findlay
Address: Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
Email: Mandi S Newton* - mandi.newton@ualberta.ca; Shannon Scott-Findlay - shannon.scott-findlay@ualberta.ca
* Corresponding author    
Abstract
Background:  In the past 15 years, knowledge translation in healthcare has emerged as a
multifaceted and complex agenda. Theoretical and polemical discussions, the development of a
science to study and measure the effects of translating research evidence into healthcare, and the
role of key stakeholders including academe, healthcare decision-makers, the public, and
government funding bodies have brought scholarly, organizational, social, and political dimensions
to the agenda.
Objective: This paper discusses the current knowledge translation agenda in Canadian healthcare
and how elements in this agenda shape the discovery and translation of health knowledge.
Discussion:  The current knowledge translation agenda in Canadian healthcare involves the
influence of values, priorities, and people; stakes which greatly shape the discovery of research
knowledge and how it is or is not instituted in healthcare delivery. As this agenda continues to take
shape and direction, ensuring that it is accountable for its influences is essential and should be at
the forefront of concern to the Canadian public and healthcare community. This transparency will
allow for scrutiny, debate, and improvements in health knowledge discovery and health services
delivery.
Background
The knowledge translation agenda remains at the fore-
front of international debate and concern, with extensive
focus on the large gap that remains between research
knowledge and healthcare practice. Indeed, the transla-
tion of basic scientific knowledge into clinical studies and
the translation of clinical studies into improvements in
healthcare practices remain two major obstacles in the
knowledge translation agenda [1,2]. Much-cited studies
from the US and the Netherlands suggest that 30 to 40%
of patients do not receive treatment complying with cur-
rent research evidence, 20 to 25% of the care provided to
patients is not needed or may be potentially harmful [3-
5], and that treatment implementation has occurred
before being proven beneficial [6].
In healthcare and in health research, the knowledge trans-
lation agenda has gained increasing importance as a
means to promote evidence-based practice and policy,
with the intended goal being improved healthcare out-
comes. Within the knowledge translation field, consider-
able theoretical and polemical discussions have
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transpired concerning what evidence is [7-12] and what
constitutes evidence-based practice and policy [13-16].
Methods for studying knowledge translation have been
developed, and studies evaluating the translation of
research evidence into healthcare practices have been con-
ducted [17-27]. There has been concomitant debate on
who should be accountable for health research transla-
tion. To date, literature has focused on roles and responsi-
bilities of key stakeholder relationships [28-37], specific
roles that facilitate knowledge translation (e.g., knowl-
edge brokers, opinion leaders) [38-40], and organiza-
tional factors specific to stakeholder contexts have also
been acknowledged as integral to the knowledge transla-
tion agenda [35,36,41]. Most recently, government has
become a key stakeholder in the agenda with health
research funding agencies from across the world (e.g.,
Institute of Medicine, Medical Research Council, National
Institutes of Health, Canadian Health Services Research
Foundation, and Canadian Institutes of Health Research)
developing key funding directives and statements on the
importance of knowledge translation to healthcare to pro-
mote effective, timely, and responsible translation of
health research results. In Canada, these directives carry
key public and private investments for other stakeholders
that, in turn, shape the country's knowledge translation
agenda.
In this debate paper, we discuss the current knowledge
translation agenda in Canadian healthcare that involves
the influence of values, priorities, and people, and illus-
trate how each of these stakes shapes the discovery and
translation of health research knowledge. We conclude
with recommendations for the direction of this agenda in
light of current stakeholder interests.
Discussion
The knowledge translation agenda in Canadian healthcare
The current healthcare research agenda in Canada is a
more balanced one. There is a strong foundation in dis-
covery of new health knowledge and its translation into
the healthcare system. The research agenda prior to this
was focused almost exclusively on the creation of new
knowledge, with little funding emphasis on the actual
implementation in practice or policy. Having this new
agenda in healthcare, however, is complex; to be effective
it needs to span macro (policy, funding), meso (organiza-
tional) and individual (researcher, decision-maker, con-
sumer) levels of the health system which is itself a
complex system with competing demands from multiple
stakeholders. Adding to this complexity, is an agenda also
greatly shaped by a degree of societal accountability (e.g.,
return on investment of tax dollars earmarked for health
research) and priorities (e.g., identified needs for health-
care system improvements).
The Canadian movement for addressing how research
influences the healthcare system and patient outcomes
emerged in the early 1990s with calls in the literature for
the adoption of an evidence-based, decision making cul-
ture throughout the healthcare system [e.g., [9]]; the
National Forum on Health swiftly spurred a similar
response at a national level [42]. Borne out of these early
developments, at the macro level, are knowledge transla-
tion agendas currently endorsed by Canada's two major
health research funding agencies, the Canadian Institutes
of Health Research (CIHR) and Canadian Health Services
Research Foundation (CHSRF). Each agency offers their
respective definition of knowledge translation. For CIHR,
knowledge translation involves "... the exchange, synthe-
sis and ethically-sound application of knowledge – within
a complex system of interactions among researchers and
users – to accelerate the capture of the benefits of research
for Canadians" [43]. CHSRF uses the phrase knowledge
transfer and exchange, defined as "... collaborative prob-
lem-solving between researchers and decision makers that
happens through linkage and exchange. [It] results in
mutual learning through the process of planning, produc-
ing, disseminating, and applying existing or new research
in decision-making" [44].
Using these definitions, both agencies have established
key funding directives to encourage the translation of
health research knowledge to ultimately better influence
policy and healthcare practice decisions. CIHR stresses
accountability in the return on investment of tax dollars
that fund Canadian health research [43,45]. The intent is
clear: publicly funded health research should be carried
out in the most effective way to facilitate timely transla-
tion of research findings into health and fiscal benefits.
Since its establishment in 1999, CIHR has increased its
funding three-fold in clinical research and twenty-fold in
health systems research supporting its knowledge transla-
tion mandate [46]. Despite these funding increases, there
is sentiment that additional funds need to be dedicated to
continue to build capacity in the knowledge translation
field, and the agency has proposed further developments
to its knowledge translation portfolio [2,47]. Consistent
with its definition of knowledge transfer and exchange,
CHSRF focuses funding on applied health research
projects and clearly emphasizes the need for established
relationships between researchers, decision- and/or pol-
icy-makers to translate research findings to healthcare set-
tings [44]. While the role of Canada's funding agencies in
the knowledge translation agenda provides a transparent
process of tracking health research funds and the impact/
outputs of funded research, these positions greatly influ-
ence the country's research agenda and shape issues
related to timing, translation ethics, and accountability.Implementation Science 2007, 2:32 http://www.implementationscience.com/content/2/1/32
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Judicious knowledge translation
While the translation of basic scientific 'bench' discoveries
into clinical studies and the translation of clinical studies
into improvements in health care practices remain two
major obstacles in the health care system, there are no
definitive timeframes from Canada's funding agencies to
promote research advancement that addresses these limi-
tations. Indeed, it may take years or decades before a body
of research accumulates to provide an ethical and sound
direction for health system impact. Further, research
advances often involve the coordination of contributions
from more than one scientific field (e.g., basic and clinical
researchers from nanotechnology, engineering, medicine,
etc.). CIHR accounts for this important timing issue in its
caveat of 'ethically-sound application' in its definition,
but the message may not be clear enough to researchers
when considered alongside the agency's expectations for
knowledge translation. In a recent paper, the notion of
judicious translation was brought forth by CIHR which
fits well with this dilemma [2]. In their article, Graham
and Tetroe stress that "while researchers are encouraged to
translate the results of their studies, they need to be
thoughtful about their message and who the appropriate
audience is for this message" [[2]; pg 21].
We agree with this position; there is indeed an important
ethical component to the knowledge translation agenda
that should not be diminished in the effort to close the
gap between 'bench and bedside'. The knowledge transla-
tion movement in healthcare can give rise to good-inten-
tioned researchers, decision-makers, and policy-makers
prematurely implementing evidence and/or interventions
when there is an insufficient knowledge base to be confi-
dent in its impact; a concern and reality already echoed in
the literature [3-6,48]. The sense of urgency to translate
for public greater good and system improvements should
be tempered with clear messages that translation is an eth-
ically-bound process that should be judiciously
appraised. In this sense, a distinction is made between
what knowledge translation is to healthcare (e.g., translat-
ing evidence into healthcare practice to promote system
improvements) versus what knowledge translation is to
health research (e.g., translating research evidence into the
scientific community via publication for scrutiny and/or
translating evidence into healthcare practice for study). A
natural debate that emerges from this distinction, but is
debatable beyond the scope of this paper, is the applica-
tion of best available evidence versus best evidence.
The emphasis by Canada's funding agencies on engaged
activities between researchers and decision- and policy-
makers to promote research translation into health bene-
fits carries accountability issues and concerns regarding
scope of practice. There is potential for considerable
impact on these stakeholders. Little research has empiri-
cally examined the activities of Canadian health research-
ers, and whether these actually align with the country's
current funding agendas [49]. Of concern is the potential
tension between funding agency directives and the system
that health researchers function in, an environment that
expects researchers to ascend through the academic ranks
via established publication and grant dollar benchmarks.
Effort afforded to establishing connectivity with and prod-
ucts essential to decision- and policy-makers for transla-
tion is under-rewarded, if unrewarded, by university
tenure and promotion systems carrying the potential of
unintended adverse career effects [41,50]. The same situa-
tion can be afforded to decision- and policy-makers who
are evaluated by performance standards that are not well-
aligned with funding agency directives that encourage/
expect involvement in the research process and transla-
tion efforts whose products often extend beyond formal,
evaluative time spans in healthcare organizations.
To meet the contemporary demands of Canadian funding
agencies and those of university tenure and promotion,
researchers need to consider a portfolio that includes tra-
ditional knowledge translation expectations (scholarly
outputs such as peer-reviewed publications) and applied
knowledge translation activity (engaged interactions with
decision- and policy-makers) [51-53]. Academic institu-
tions' values need to evolve to become more utilitarian;
knowledge discovery cannot be solely regarded and
rewarded via traditional knowledge translation activity,
but should extend to a more utilitarian standpoint where
knowledge discovery is 'hand-in-hand' with potential
implementation. The same philosophy can be applied to
decision- and policy-makers who find themselves at odds
with how to manage their portfolios. This potential solu-
tion, however, only targets individual accountability.
Accountability targeted at the organizational level should
also be expected. Within the knowledge translation
agenda are calls for the recognition and examination of
organizational factors (e.g., leadership structure, hospital
classification) and environmental factors (e.g., the health-
care delivery team, organizational culture, administrative
personnel) that shape the innovation implementation
[24,38,39,56-58]. This call should also include the exam-
ination of institutions that employ the researchers (i.e.,
academia) and decision- and policy-makers (i.e., hospi-
tals and government) as these stakeholders are also
directly embedded in the organizational and environmen-
tal systems within the healthcare system. Employer pro-
moted professional development and evaluation systems
need to be re-examined and reconstructed to reflect cur-
rent trends in the healthcare research agenda [52,53]. Pro-
fessional development should include organization-
created opportunities for relationship development and
skill-building related to research application. In Canada,
several examples exist to strengthen capacity in develop-Implementation Science 2007, 2:32 http://www.implementationscience.com/content/2/1/32
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ing relationships between researchers and decision-/pol-
icy-makers (e.g., community-university partnerships
[CUP] programs) and developing leadership and skills to
better use research information in the healthcare system,
including SEARCH Canada (Swift, Efficient Application of
Research in Community Health) [54] and the EXTRA
(Executive Training for Research Application) programs
[55]. These opportunities, however, need to be more con-
sistent in the Canadian system as a means of formal mark-
ers for professional development and work scope.
Summary
Knowledge translation in Canadian healthcare has public
and private interests that are inherently served for stake-
holders who have an influential role in knowledge crea-
tion, dissemination, and implementation to advance
health knowledge and health services delivery. Tailoring
recommendations for the knowledge translation agenda
to these interests is a first step in creating accountability
and transparency to allow for scrutiny, debate, and
improvements in health knowledge discovery and health
services delivery.
We recommend that the following need to be formally
included as part of the knowledge translation debate and
agenda in Canada:
1. The message that return on investment of tax dollars for
healthcare research via translation to system improve-
ments should be consistently tempered with the clear
message that translation is an ethically-bound process
that should be afforded to robust evidence to support its
impact [2,53]. Changes to healthcare practice and policy
demand consequential complex behaviour changes at
many different levels necessitating strong evidence bases
for the change. One only needs to look at the case of
breast screening examination research to highlight the
complexity and intricacy of interpreting research in a
manner that guides clinical decisions, particularly when
research calls accepted clinical practices into question.
This process of interpretation of research is neither
straightforward nor easy, but rather, involves time and
developed skill to access, understand, critique, and reflect
on research results in light of one's practice and experi-
ence.
2. Accountability for the knowledge translation agenda
should span macro, meso, and micro levels. At the macro
and meso levels, funding agencies, government (federal,
provincial, municipal), healthcare organizations, and aca-
demic institutions need to align organizational directives
related to knowledge translation of robust evidence. We
need to begin publicly discussing what resources should
be expected from employers to promote engaged knowl-
edge translation activity, and how should these activities
be recognized in work scope and career advancement. As
the demand for research knowledge has become more
utilitarian, in response, stakeholders will be more effec-
tual if they adopt a process to address utilitarian complex-
ities [41]. At the micro level, consideration should also
start to be given as to how other public and private entities
(e.g., advocacy groups, media) can assume responsibility
in the knowledge translation agenda. At this level, the
peer-review process in evaluating research findings also
warrants examination. The role of editors in publishing
robust null/negative and replicated health research find-
ings for peer and public scrutiny is a necessary component
to the translation agenda. Publication bias involving pos-
itive results and the emphasis on publishing novel find-
ings versus replicated studies can skew the landscape of
health-related issues [53].
3. Organizational research should include an examina-
tion of institutions that employ the researchers and deci-
sion- and policy-makers as these stakeholders are also
directly embedded in the organizational and environmen-
tal systems within the healthcare system. Further, organi-
zationally-oriented research needs to include more
sophisticated analytic work, such as the development of
statistical models that demonstrate how the identified
organizational features (e.g., organizational size, organi-
zational complexity, organizational slack, resources)
interact and work.
Conclusion
In Canada, there has been increasing pressure to demon-
strate both accountability and transparency in healthcare
decision-making; the translation of research to the health-
care system has been a frequently accepted strategy to
accomplish these demands. However, this knowledge
translation agenda has public and private interests that are
inherently served for current stakeholders who have an
influential role in knowledge creation, dissemination,
and implementation to advance health knowledge and
health services delivery. As this agenda continues to take
shape and direction, ensuring that it is accountable for its
influences is essential and should be at the forefront of
concern to the Canadian public and health research com-
munity. This transparency will allow for scrutiny, debate
and improvements in health knowledge discovery and
health services delivery.
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